The use of total hip arthroplasty (THA) continues to grow partially because of the increasing life expectancy of the American population. Whether to use cemented or cementless femoral fixation options in older patients is often debated. The purpose of the present study was to compare the clinical and radiographic outcomes after cementless THA in patients 80 years to younger patients. Clinical and radiographic data were gathered on 33 patients (35 hips) all 80 years or older who had undergone proximally coated cementless total hip arthroplasties. Outcomes were compared with a matching group for age, body mass index, and diagnosis, who had undergone the same procedure by the same surgeon at a similar time. Harris hip scores were evaluated pre-and postoperatively, and radiographs were reviewed for evaluation of fixation and stability. At a mean follow-up of 4 years, 97% of the hips (34 of 35) remained unrevised and the mean Harris hip score had improved by 39 points to 83 points (range, 26-100 points). On radiographic evaluation, 91% were found to have full bony ingrowth, with 1 hip having osteolysis of the proximal femur. Mortality was 23% at 86 months. Except for mortality, the outcomes and complication rates were similar to the younger group except that the matching group had higher final postoperative Harris hip scores. Proximally coated tapered cementless THA is a safe and efficacious method for providing good clinical outcomes with low revision rates in patients 80 years of age or older.
Introduction
Total hip arthroplasty (THA) remains the treatment of choice for end-stage degenerative disease of the hip, with excellent long-term effectiveness in relieving pain and improving function in most patients. 1 While it is becoming more common for younger patients to receive hip arthroplasties, elderly patients continue to comprise the large majority of patients treated. As the mean life expectancy and proportion of elderly individuals continues to increase 2,1 and more people maintain active lifestyles well past retirement age, the number of individuals aged 80 years and older being considered for THA can be expected to increase as the total number of hip replacements performed in the United States by 2030 is expected to be more than 500 000. 1 The best form of femoral fixation in older patients remains debatable. Ranawat et al cite a higher learning curve, longer recovery time, greater incidence of thigh pain, higher cost, and more difficult revision as reasons to avoid cementless arthroplasty in patients over 60 years of age. 3 Conversely, Engh and Leung suggest that cementless arthroplasties are preferred for patients over 60 years of age because of their predictable survivorship (95% beyond 10 years) and ease of implantation. 4 Multiple studies have suggested that results from proximally coated cementless stems are excellent in a non-age-selected population. 5 However, older patients may have altered bone quality, as well as decreased bone metabolism and remodeling, potentially compromising the fixation and stability of cementless implants in these patients. The use of cementless tapered stems has shown excellent results in some studies 6 but is still not fully accepted.
The purpose of this study was to evaluate the clinical and radiographic outcomes, as well as medical complication rates, of proximally coated tapered cementless stems for total hip arthroplasties in patients 80 years of age or older at the time of index surgery to compare these outcomes with those found in a non-age-selected group of patients who underwent the same procedure over the same time period.
Methods
A prospectively collected database of patients treated with THA at a single center was reviewed to identify those patients who were 80 years of age or older at the time of primary THA and who received a proximally coated tapered cementless implant. All patients had a minimum follow-up of 24 months (see Table 1 ). A total of 33 patients (35 hips) were identified, consisting of 17 women and 18 men who had a mean age of 85 years (range, 80-90 years) at the time of their index arthroplasty and had a mean body mass index of 27 kg/m 2 (range, 20-38 kg/m 2 ). The most common preoperative diagnosis was osteoarthritis (33 of 35 hips). One patient was diagnosed with osteonecrosis and another received an arthroplasty to treat a nonunion after a dynamic hip screw was originally inserted for an intertrochanteric fracture. Institutional review board approval was sought and granted for this study.
Eight patients had died since having their arthroplasty procedure (23%). All patients had a minimum follow-up of 24 months, and they had a mean Harris hip score of 87 points (range, 69-99 points) at final follow-up. Since all patients had well-functioning prostheses at the time of death, they were included in the study.
All procedures were performed using an anterolateral approach by the senior author (M.A.M.), with implantation of an Accolade proximally coated cementless femoral component (Stryker Orthopaedics, Mahwah, New Jersey), with a Trident acetabular shell (Stryker Orthopaedics). All patients received intensive in-hospital rehabilitation for 1 to 6 days and postoperatively for up to 12 weeks. On the first postoperative day, the patients were encouraged to walk with an assistive device. Initially, weight bearing was limited to 50% for 5 to 6 weeks following surgery, at which time the patients were advanced to full weight bearing. At 10 to 12 weeks following surgery, the patients were given a series of hip strengthening exercises to perform at home when formal physical therapy was discontinued.
Patients were followed clinically and radiographically at approximately 3 months, 6 months, 1 year, and annually afterward. The mean follow-up time was 48 months (range, 24-90 months).
Clinical outcomes were evaluated at each follow-up visit using the Harris hip score to monitor pain, function, and range of motion. Patient records were also reviewed for all surgical and medical complications that occurred in the postoperative period. Surgical complications included infection, dislocation, intractible pain, superficial cellulitis, peroneal nerve palsy, heterotopic ossification, and periprosthetic fracture. Medical complications were urinary tract infection, cardiac abnormalities, myocardial infarction, cerebrovascular accident, neurologic disturbances, deep vein thrombosis, and pulmonary embolism.
Radiographic outcomes were assessed using the most recent standing anteroposterior and lateral films and were reviewed for progressive radiolucencies, and changes in component alignment or frank component migration. Immediate postoperative evaluation for each patient indicated a stable implant.
The clinical and radiographic outcomes were compared with a previously described matched comparison group of non-ageselected patients treated, who underwent THA with the same model of femoral stem at the same center over the same time period. Each patient was matched by sex (exact match), preoperative diagnosis (exact match), and body mass index (+4 kg/m 2 ). The mean follow-up time for the matched group was 43 months (range, 24-72 months), which was similar to the study group (P ¼ .153).
All data collected for these patients were aggregated and analyzed using Excel spreadsheet software (version 11, Microsoft Corporation, Redmond, Washington). Statistical analyses were performed using SigmaStat software (version 3.0, SPSS Incorporated, Chicago, Illinois), with the paired t used to compare survivorship and complication rates. All statistical comparisons were conducted using 95% confidence intervals, where a P value of less than .05 was considered significant.
Results
At final follow-up, there was 97% survivorship (34 of 35 hips) in the cohort of over 80 years of age, while the comparison group had a survivorship of 94% (33 of 35 hips). The mean Harris hip score for the patients over 80 years of age improved from a mean preoperative value of 42 points (range, 18-70 points) to 78 points (range, 43-100 points) postoperatively. The clinical outcomes, radiographic outcomes, and complications are summarized in Table 2 .
The 1 patient who was revised in the over 80 cohort was the only patient who had a diagnosis of osteonecrosis and underwent revision 12 months postoperatively at an outside institution for intractable pain and a limp that required the use of a walker. Forty-eight months after revision surgery, the patient is doing well with a Harris hip score of 86. In the cohort of patients over 80 years of age, there were 3 patients who had Harris hip scores less than 80 points. The patient who reported a Harris hip score of 43 points at final follow-up reported this score after a traumatic fracture of the distal femur on the implanted side. The patient was treated with an intramedullary rod. Despite radiographic evidence of fracture callous formation, the patient had considerable residual pain at the time of follow-up, accounting for the low Harris hip score. The next lowest Harris hip scores were 64 points, recorded in 2 patients (one who presented for unrelated back pain causing difficulty with ambulation, and another who experienced profound muscle weakness after a stroke). Upon radiographic examination, 34 prostheses in the study cohort were found to be stable with no evidence of loosening. There was no incidence of symptomatic heterotopic ossification, but 2 patients had asymptomatic heterotopic ossification (1 Booker grade II and 1 grade III). Additionally, 1 patient 7 showed 3 mm of osteolysis in the femur in Gruen zone 6. There was no subsidence, the patient was asymptomatic, and the lesion did not increase in size on serial radiographs. Radiographic evaluation in the control group revealed well-fixed components with no radiolucencies in 33 cases and 2 instances of heterotopic ossification (1 Brooker grade II and 1 grade III).
In the matched comparison group, the Harris hip scores improved from a mean score of 39 points (range, 7-68 points) preoperatively to 83 points (range, 50-100) postoperatively. Both revisions in the comparison cohort were performed for recurrent dislocations. One was performed 9 months postoperatively and the other at 24 months. The first patient has done well, with a Harris hip score of 89 points 7 years postoperatively; the other patient was subsequently infected 24 months after revision with methicillin-resistant Staphylococcus aureus and required a 2-stage revision. The patient remains infection free at 24 months follow-up.
Complication rates related to the THA were similar between the 2 groups. There was 1 patient (3%) who dislocated in the octogenarians and 2 patients (6%) in the control group (P ¼ 1.0). The patient in the over 80 cohort, however, did not require revision surgery for dislocation and was successfully relocated under anesthesia. There were no peroneal nerve palsies in the octogenarian cohort, while there was 1 symptomatic foot drop that required peroneal nerve release in the control group. There were 2 patients in each cohort who had heterotopic ossification (P ¼ 1.0). There was a small, but statistically insignificant difference in the total number of medical complications between the 2 groups, with 4 medical complications (11%) occurring in the over 80 group, compared to none in the control group (P ¼ .11). In the octogenarians, there were 2 urinary tract infections and 2 postoperative arrhythmias that required cardiac consultation. There was no incidence of pulmonary embolism, myocardial infarction, or cerebrovascular accidents with 30 days of the arthroplasty surgery.
Discussion
Peri-and postoperative complications always have the potential to cause significant morbidity and mortality; in elderly patients these complications, including dislocation, peroneal nerve palsy, pulmonary embolism, and perioperative myocardial infarction or cerebrovascular accident, can prove even more devastating. 8, 9 Because of these risks, surgeons may be apprehensive to perform elective surgeries on an otherwise healthy octogenarian, despite several successful reports of high survivorship of THA in this older population. 10, 11, 6 We therefore wanted to evaluate the survivorship of proximally coated cementless tapered stems in patients who were over 80 years of age and to specifically assess the peri-and postoperative complication rates. The infrequency of these complications, coupled with low revision and dislocation rates, and radiographic evidence of stable components, suggest the safety and efficacy of this procedure in patients over 80 years of age. Previously reported results for cementless THA in patients over 80 years show similar outcomes and survivorship to the current study. Keisu et al reported on 92 cementless proximally coated tapered stem total hip arthroplasties in 86 patients in 2001, who were 80 years of age or older, and who had a mean follow-up of 5 years (range, 2-11 years). 6 There were no revisions of the femoral component, although there were 4 patients who reported mid-thigh pain. This pain, however, did not limit their activity. They additionally showed a mean improvement in Harris hip scores of 42 points. Radiography confirmed stability in all hips with only 1 case of osteolysis, and complications included 1 femoral nerve palsy (0.8% of hips), 8 pulmonary emboli (6.5% of hips), and no femoral or acetabular fractures. These complications were not observed in our report. In 2003, Pieringer et al followed 80 hip arthroplasty patients who had a mean age of 83 years (range, 80-92 years) who received cementless fully coated tapered femoral components, and found that, at a mean of 69 months of follow-up, the mean Harris hip score for these patients was 82 points. 10 Ogino et al studied 6540 hip arthroplasty patients who had a mean age of 83 years (range 80-97 years), of whom 399 (6%) received a cementless implant, and found a 5-year Kaplan-Meier survivorship of 95% for patients with cementless implants. 11 The current study shows outcomes and complication rates that are similar to or more favorable than those reported for cemented arthroplasty in patients over 80 years of age (see Table 3 ). Cemented arthroplasty in patients older than 80 years has been shown to decrease pain, improve function, and increase range as measured by the Harris hip score reported at up to 5 years' follow-up 1, 12, 9, 8, 13 . Pettine et al compared 91 patients (101 hips) who had a mean age of 83 years (range, 80-100 years) to matched controls with a mean age of 66 years (range, 64-67 years), all of whom underwent cemented THA. 9 The over 80 group experienced a higher rate of major postoperative complications such as pulmonary embolism, dislocation, and myocardial infarction (7 of 101 cases vs 2 of 101 controls). Mean Harris hip scores were similar between the groups (84 for cases vs 88 for controls). Wurtz et al reported on 40 patients (46 hips) who had a mean age of 83 years (range, 80-92 years) and who underwent hybrid total hip replacement with a cemented femoral component and cementless acetabulum. 8 Postoperative complications occurred in 15% of hips (6 of 46 hips) and included dislocation, infection, and peroneal nerve palsy. At a mean follow-up of 48 months, most patients were pain free (37 of 46 hips, 80%) and walked without assistance (32 of 46 hips, 70%). Radiographic results showed stability in all components at a mean of 39 months, with 3 cases of heterotopic ossification. The complications reported in the present study in the patients over 80 years were minimal, with a single patient that dislocated (that did not require operative treatment), no incidence pulmonary embolism, myocardial infarction, or cerebrovascular accidents in the immediate postoperative period. The peroneal nerve palsy occurred only in the control group. There was, however, a slightly higher, but statistically insignificant, incidence of minor complications including urinary tract infection and transient cardiac arrhythmias. Although these complications did not affect the functional outcomes of the hip arthroplasties, the surgeon should be aware of these types of complications, and watch for them, specifically in their older patients.
The limitations of this study include the relatively short follow-up, small number of patients, and high mortality in the group over 80 years of age. Also, the high prevalence of comorbidities in patients over 80 years of age adversely affects the functional hip score. In patients with osteoporotic bone it is difficult to distinguish whether postoperative fractures are primarily driven by the arthroplasty or by normal pathophysiology. All patients in this study were instructed to remain at 50% weight bearing for 6 weeks postoperatively, as opposed to weight bearing as tolerated, which could have perhaps further reduced the likelihood of fracture in this population. Additionally, this study was performed by a high-volume hip surgeon who routinely uses a proximally coated tapered stem. The possibility for intraoperative femur fracture should be taken into account when performing hip arthroplasty in octogenarians. Nevertheless, we believe that this study presents an accurate overview of the clinical results and complications of proximally coated cementless THA in patients over 80 years of age.
All patients but 1 did not require revision during the study period, suggesting that proximally coated cementless femoral components have excellent survivorship. Compared with non-age-matched controls, patients over 80 years of age benefit from similar improvements in clinical outcomes and have similar radiographic outcomes. While clinical outcomes measured by Harris hip score tended to be slightly higher in controls, the vast majority of patients over 80 years of age achieved and maintained good Harris hip scores over the study period. These results suggest that proximally coated cementless THA is a safe and efficacious method for providing excellent clinical outcomes and low revision rates in patients 80 years or older. 
